Aktiia is a company focused on providing continuous and accurate blood pressure monitoring to address hypertension, a prevalent chronic condition affecting over 1.4 billion people globally. Founded on two decades of research, Aktiia has developed a unique tool that combines optical sensors with clinically validated software algorithms to measure blood pressure at the wrist. This innovative approach enables individuals to gain insights into their blood pressure patterns and understand the underlying causes of hypertension. By delivering personalized, continuous, and medical-grade blood pressure and heart rate data, Aktiia aims to enhance patient care and empower patients, researchers, and clinicians. The company's mission is to improve the accessibility, accuracy, and actionability of blood pressure management, ultimately contributing to better health outcomes and reducing the significant mortality associated with high blood pressure.
Poppins
Venture Round in 2025
Poppins is a developer of digital therapeutic technology aimed at enhancing cognitive function in children with learning disorders. The company creates interactive musical games that integrate neurologic music therapy methods to address conditions such as dyslexia, dysphasia, and dyspraxia. These games focus on improving essential skills like concentration, motor skills, and memory through engaging activities that can be performed at home. By leveraging data science and advanced technologies, Poppins interprets learning, language, and motor performance to generate a cognitive score, facilitating personalized treatment plans. The company's mission is to provide accessible digital solutions for children facing learning challenges, ultimately aiming to improve their reading abilities and memory retention while supporting speech therapy.
Zero Point Motion
Seed Round in 2025
Zero Point Motion develops inertial sensing technology for precise positioning and navigation, combining cavity optomechanics with a hybrid micro-electro-mechanical system and photonic integrated circuit technology to deliver ultra-low-noise readouts of acceleration and rotation; its sensors include ultra-sensitive accelerometers and gyroscopes built on silicon photonics, enabling high-accuracy motion sensing for demanding applications, including defense, agritech, and autonomous vehicles.
Lexroom.ai
Seed Round in 2025
Lexroom.ai allows lawyers to complete hours of legal research in seconds.
Legal professionals spend up to 50% of their time in repetitive, low value-adding tasks. That’s why we’re building Lexroom.ai, a product that allows lawyers to complete hours of research in seconds, so they can focus on what really matters.
Lexroom.ai perfectly integrates with lawyers' daily workflow and enables them to speed up time-consuming legal research tasks while increasing output quality, so that they can focus more on value-adding activities.
Lexroom.ai is building a bridge between advanced artificial intelligence technologies and legal professionals, through a product specifically tailored to their needs.
Orakl Oncology
Seed Round in 2024
Orakl Oncology specializes in expediting cancer drug discovery by employing advanced biology and AI-driven analysis. It maintains a unique collection of patient tumor avatars, integrating biological and clinical data, to create realistic tumor models that mimic real-life drug responses. By mining multi-modal experimental data and combining it with deep patient data, Orakl enables oncology companies to identify relevant targets and develop more effective treatments at an accelerated pace.
Metafuels
Series A in 2024
Metafuels develops sustainable aviation fuel technology, aerobrew™, designed to produce e-kerosene affordably and at scale. This innovative process uses renewable feedstocks like green hydrogen and sustainably sourced CO2, contributing significantly to global aviation's decarbonization efforts.
Tozero, founded in July 2022 in Munich, Germany, by Sarah Fleischer and Dr. Ksenija Milicevic Neumann, specializes in lithium-ion battery recycling technology. The company aims to accelerate decarbonization efforts by developing a scalable and sustainable machine for recovering critical materials such as lithium, nickel, cobalt, graphite, and manganese from various battery types. By enabling industries to reintroduce these valuable raw materials into the supply chain, Tozero contributes to more sustainable practices in battery production and reduces dependency on virgin resources.
Otoqi develops an automotive management platform that streamlines vehicle logistics throughout their lifecycle. Its solutions include delivery services, concierge transfers between sites, fleet management, and more, enabling dealerships to enhance operational efficiency, improve customer satisfaction, and drive sales growth.
RetinAI Medical AG, founded in 2016 and headquartered in Bern, Switzerland, focuses on developing innovative software tools for the collection, organization, and analysis of eye health data. The company offers products such as OmniViewer, which enables researchers to annotate and structure both 2D and 3D datasets for machine learning and statistical analyses, and Discovery, designed for clinical and pharmaceutical research. RetinAI aims to optimize and simplify workflows in clinics and research environments, enhancing healthcare delivery by leveraging advanced machine learning for automatic image and data analysis. Its proprietary technology significantly improves image quality and facilitates the automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies, and device manufacturers, achieving performance levels comparable to human analysis.
Nuclera specializes in accelerating drug discovery by providing a protein prototyping system. Its eProtein Discovery™ platform enables scientists to rapidly produce and test proteins for research purposes.
Somagenetix
Series A in 2024
Somagenetix is a biotechnology company specializing in gene therapy aimed at treating phagocyte-related illnesses. The firm focuses on developing innovative treatments for conditions such as immunodeficiency, neurodegeneration, and cancer with brain metastases. By utilizing genetically modified phagocytes, Somagenetix seeks to improve patient outcomes through targeted therapies. Additionally, the company is engaged in the discovery and development of stem cells derived from bone marrow and therapeutic genes from lentiviral vectors. This approach enables the correction of underlying genetic defects and the transplantation of gene-corrected cells back into patients, with the goal of curing various monogenetic diseases. Through its pioneering efforts, Somagenetix aspires to be a leader in the gene therapy sector.
Neo Medical
Series B in 2024
Neo Medical SA is a medical technology company based in Villette, Switzerland, with additional offices in Germany, France, and the United States. Founded in 2013, the company specializes in developing, manufacturing, and commercializing non-constraint thoraco-lumbar spinal fusion systems for spinal surgery. Its flagship product, the Neo Pedicle Screw System, offers a range of functionalities such as reduction, compression, distraction, and screw augmentation, addressing various pathologies including degenerative conditions, tumors, and trauma. Neo Medical aims to enhance the efficiency of healthcare delivery by providing versatile and high-quality surgical solutions, thereby contributing to the ongoing pursuit of healthcare cost optimization.
Puraffinity
Series A in 2024
Puraffinity specializes in designing and developing precision materials for water treatment. Founded in 2015 and based in London, it has pioneered a sustainable novel adsorbent capable of removing challenging pollutants from contaminated water and wastewater. Utilizing advanced supramolecular chemistry methods, Puraffinity's technology binds target chemicals to functionalized sustainable materials, addressing imminent water quality challenges while promoting positive environmental impact.
Founded in Munich, Germany in 2017, IRUBIS specializes in manufacturing Mid-Infrared (MIR) spectrometers and Attenuated Total Reflection (ATR) crystals. The company combines semiconductor technology with infrared spectroscopy to develop devices for analyzing protein-based drugs. IRUBIS offers a real-time bioprocess monitoring system using MIR spectroscopy, which measures glucose and lactate online without contamination risk. They also provide ATR crystals and accessory solutions.
Cubbit is a geo-distributed cloud enabler that repurposes underutilized edge resources into B2B cloud services. Its DS3 software runs anywhere—on existing hardware, in the cloud, or at the edge—creating a seamless single data domain and a hyper-resilient cloud object storage under the user’s sovereignty. The platform requires no upfront investment and can help organizations reduce storage costs and minimize cloud carbon footprint, giving enterprises and service providers greater control over data, infrastructure, and costs across on-premises, multi-cloud, and edge deployments.
Axelera AI
Series B in 2024
Axelera AI specializes in developing hardware and software platforms designed to accelerate artificial intelligence tasks, particularly for edge computing. Its flagship product, the Metis™ AI Platform, integrates both hardware and software components to deliver high-performance, energy-efficient AI inference solutions. The company is headquartered in Eindhoven with R&D offices in Belgium, Switzerland, and Italy.
Neustark
Venture Round in 2024
Neustark develops sustainable construction materials by capturing emissions generated in concrete production and converting them into climate-positive limestone, providing an alternative to cement and sand that are key cost drivers in concrete manufacture. The company also offers environmental services that recycle construction waste into fresh concrete, dismantling waste into carbonate powder and gravel components to enable reuse in new mixes. Together, these approaches support decarbonization and circularity in the construction sector by lowering embodied emissions, reducing material costs, and turning waste streams into usable construction material.
C12 Quantum Electronics
Venture Round in 2024
C12 Quantum Electronics is a company based in Paris, Ile-de-France, France, founded in 2019 by Pierre and Matthieu Desjardins. The company focuses on developing reliable quantum processors utilizing carbon nanotubes, which significantly reduce error rates. This technology positions C12 Quantum Electronics as a strong candidate for noisy intermediate-scale quantum applications. In addition to building quantum computers, the company also engages in developing and accelerating experiments related to information processing systems, allowing industrial clients to leverage intermediate-scale quantum applications for enhanced computing capabilities.
Limula develops an automated cell therapy manufacturing platform that combines bioreactor and centrifuge capabilities into a single device, supported by hardware, software, and consumables. The platform enables scalable, decentralized production of cell therapies by bringing manufacturing closer to patients and supporting multiple cell types. It automates complex processing steps within a closed, modular system, allowing biotech and pharmaceutical companies to move from open, manual methods to automated operations, improving efficiency, safety, and accessibility of personalized treatments.
RetinAI Medical AG, founded in 2016 and headquartered in Bern, Switzerland, focuses on developing innovative software tools for the collection, organization, and analysis of eye health data. The company offers products such as OmniViewer, which enables researchers to annotate and structure both 2D and 3D datasets for machine learning and statistical analyses, and Discovery, designed for clinical and pharmaceutical research. RetinAI aims to optimize and simplify workflows in clinics and research environments, enhancing healthcare delivery by leveraging advanced machine learning for automatic image and data analysis. Its proprietary technology significantly improves image quality and facilitates the automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies, and device manufacturers, achieving performance levels comparable to human analysis.
Bcomp Ltd., founded in 2003 and headquartered in Fribourg, Switzerland, specializes in manufacturing natural fiber composites. The company's primary products include ampliTex (natural flax fiber), bCores (lightweight wood core), and powerRibs (natural fiber composite reinforcement). Bcomp serves industries such as sports, automotive, acoustics, aerospace, electronics, design, and leisure by providing eco-friendly alternatives to traditional materials.
Artiria Medical
Series A in 2024
Artiria Medical develops innovative guidewire systems designed to enhance navigation during neurovascular procedures. Its products feature dynamic tip deflection, superior torque transmission, a high-quality hydrophilic coating, smooth intravascular navigation, adjustability, and a controlled tip deflection mechanism. These devices aim to facilitate complex interventions, reduce procedure-related risks, and improve overall efficiency.
Aktiia is a company focused on providing continuous and accurate blood pressure monitoring to address hypertension, a prevalent chronic condition affecting over 1.4 billion people globally. Founded on two decades of research, Aktiia has developed a unique tool that combines optical sensors with clinically validated software algorithms to measure blood pressure at the wrist. This innovative approach enables individuals to gain insights into their blood pressure patterns and understand the underlying causes of hypertension. By delivering personalized, continuous, and medical-grade blood pressure and heart rate data, Aktiia aims to enhance patient care and empower patients, researchers, and clinicians. The company's mission is to improve the accessibility, accuracy, and actionability of blood pressure management, ultimately contributing to better health outcomes and reducing the significant mortality associated with high blood pressure.
Groover is an innovative platform designed specifically for independent artists, focusing on music promotion and discovery. It has cultivated a community of 200,000 artists across more than 186 countries. The platform allows musicians to directly submit their music to media outlets, radio stations, playlists, and record labels, ensuring they receive valuable feedback from a vetted network of 3,000 music curators and professionals. With over two million feedback interactions on tracks, Groover provides artists with the opportunity to obtain honest insights and tangible sharing proposals, facilitating their growth and visibility in the competitive music industry.
Transmutex
Series A in 2024
Transmutex is a Swiss company founded in 2019 that specializes in innovative nuclear technology aimed at significantly reducing existing nuclear waste. The company leverages advanced techniques, including particle accelerators, to transmute long-lived nuclear waste into less harmful materials while simultaneously generating carbon-free energy. This energy can be reintegrated into the power grid or utilized for green hydrogen production. Comprising a diverse team of physicists, computer scientists, and environmentalists, Transmutex is pioneering a new approach to nuclear energy that offers scalable, carbon-free solutions without the typical challenges associated with conventional nuclear power plants.
CellVoyant
Seed Round in 2024
CellVoyant Technologies Limited is an innovative biotechnology company founded in 2021, focused on developing advanced stem cell-based therapies to address chronic diseases. The company employs an AI-first approach, utilizing live cell imaging technology to predict and optimize stem cell differentiation, which allows for the scalable and precise manufacturing of any human cell and tissue. CellVoyant's technology is rooted in pioneering research from the Carazo Salas lab at the University of Bristol, merging expertise in cell biology, computer vision, engineering, and machine learning. Led by Founder and CEO Rafael Carazo, the company aims to translate cutting-edge scientific advancements into real-world applications, addressing critical healthcare challenges. With a commitment to transforming the biotechnology landscape, CellVoyant is positioned to deliver effective, life-changing therapies to patients globally.
rready offers a SaaS platform for innovation management, empowering employees to drive intrapreneurship. It facilitates idea sourcing, validation, and implementation, fostering cultural change and generating business impact.
Fractory
Venture Round in 2023
Fractory is an online platform facilitating sheet metal fabrication. It connects users with partner service providers for various processes like laser cutting, plasma cutting, and metal bending. Incorporated in 2019, Fractory operates globally to streamline manufacturing.
Memo Therapeutics
Series C in 2023
Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.
Poppins
Venture Round in 2023
Poppins is a developer of digital therapeutic technology aimed at enhancing cognitive function in children with learning disorders. The company creates interactive musical games that integrate neurologic music therapy methods to address conditions such as dyslexia, dysphasia, and dyspraxia. These games focus on improving essential skills like concentration, motor skills, and memory through engaging activities that can be performed at home. By leveraging data science and advanced technologies, Poppins interprets learning, language, and motor performance to generate a cognitive score, facilitating personalized treatment plans. The company's mission is to provide accessible digital solutions for children facing learning challenges, ultimately aiming to improve their reading abilities and memory retention while supporting speech therapy.
Orakl Oncology
Seed Round in 2023
Orakl Oncology specializes in expediting cancer drug discovery by employing advanced biology and AI-driven analysis. It maintains a unique collection of patient tumor avatars, integrating biological and clinical data, to create realistic tumor models that mimic real-life drug responses. By mining multi-modal experimental data and combining it with deep patient data, Orakl enables oncology companies to identify relevant targets and develop more effective treatments at an accelerated pace.
Nagi Bioscience
Series A in 2023
Nagi Bioscience develops automated testing devices that use Caenorhabditis elegans worms to screen molecules for pharmaceutical, chemical and cosmetic applications. Its Organism-on-Chip platform combines whole-organism biology with an automated in vitro workflow for culture, treatment, and multi-parametric analysis, enabling toxicity testing, drug discovery, and anthelmintic screening. The technology links in vivo worm models with a fully automated platform to observe biological responses that emerge at the whole-organism level. The company is headquartered in Lausanne, Switzerland.
MedTrace Pharma
Venture Round in 2023
MedTrace Pharma A/S, founded in 2015 and based in Kongens Lyngby, Denmark, specializes in the development of innovative solutions for positron emission tomography (PET) imaging. The company has created an automated system, known as MT-100, which efficiently produces and injects 15O-water, a radioactive tracer essential for enhanced imaging. This system is designed to integrate seamlessly with in-house cyclotrons and PET scanners, significantly increasing the sensitivity of patient analysis while improving throughput by up to four times compared to conventional methods. Additionally, MedTrace Pharma develops the aQuant analytical platform, which aids in interpreting PET scan results, further optimizing the diagnostic process. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace is focused on advancing the capabilities of clinical imaging through automation and innovative technology.
Founded in 2018, DRUID AI is a leading enterprise AI platform that empowers teams to rapidly develop and deploy intelligent agents, knowledge bases, and apps. Its AI Agents facilitate personalized, secure interactions across channels, integrating seamlessly with existing systems and RPA technologies. With over 200 partners and 300 clients worldwide, DRUID AI aims to provide each employee with an intelligent virtual assistant.
Hylomorph
Series B in 2023
Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.
Puraffinity
Series A in 2023
Puraffinity specializes in designing and developing precision materials for water treatment. Founded in 2015 and based in London, it has pioneered a sustainable novel adsorbent capable of removing challenging pollutants from contaminated water and wastewater. Utilizing advanced supramolecular chemistry methods, Puraffinity's technology binds target chemicals to functionalized sustainable materials, addressing imminent water quality challenges while promoting positive environmental impact.
Verity Studios
Series B in 2023
Verity Studios designs and supplies autonomous indoor drone systems and provides end-to-end drone show production for live events, theatre, and entertainment. Founded in 2014 and based in Zurich, Switzerland, the company develops synthetic swarm and stage drones and delivers global drone shows for venues and tours, with clients including Cirque du Soleil and major arenas. Its autonomous drone technology is also used in warehouse environments for inventory tracking to improve operational efficiency, reduce labor and equipment costs, and lower waste and emissions. Verity operates worldwide, offering turnkey production services and customized drone solutions for both live events and industrial applications.
Founded in 2017, ChargeX designs and manufactures electrical charging equipment for electric vehicles. It offers Aqueduct, a modular, plug-and-play charging system with integrated load management, user-friendly dashboard, automated billing, mobile app access, and nationwide installation services. Serving residential, corporate, and infrastructural sectors, ChargeX helps clients enhance competitiveness and customer satisfaction through efficient charging infrastructure.
Turn2X specializes in developing innovative technology for producing renewable natural gas (RNG). The company converts renewable electricity from sources like solar and wind into RNG, offering industries a clean and green alternative to fossil fuels.
Axelera AI
Series A in 2023
Axelera AI specializes in developing hardware and software platforms designed to accelerate artificial intelligence tasks, particularly for edge computing. Its flagship product, the Metis™ AI Platform, integrates both hardware and software components to deliver high-performance, energy-efficient AI inference solutions. The company is headquartered in Eindhoven with R&D offices in Belgium, Switzerland, and Italy.
ANYbotics
Series B in 2023
Founded in 2016, ANYbotics develops autonomous legged robots designed for industrial applications. These robots are equipped with features such as docking stations, robust sensing capabilities, and waterproofing. They also offer tools for reading instruments, monitoring equipment health, detecting events, and inspecting complex environments. The company aims to improve worker safety, increase productivity, and support sustainable operations in industries like oil and gas, power, mining, chemicals, construction, and transportation.
ecoRobotix
Series B in 2023
ecoRobotix is a Swiss developer of autonomous weeding machines for row crops, meadows, and intercropping cultures. The company builds systems that use vision, cameras, GPS RTK, and sensors to follow crop rows, identify weeds, and guide robotic arms to apply micro-doses of herbicide directly to target weeds, enabling precision spraying and reducing chemical use. Its solutions aim to lower environmental impact and farming costs by enabling ecological and economical weed control. Founded in 2011 and based in Yverdon-les-Bains, Switzerland, ecoRobotix markets platforms that cover inter-row spaces as well as crop rows, delivering substantial reductions in chemical applications while maintaining yields.
MultiOmic Health
Seed Round in 2023
MultiOmic Health is a company focused on addressing metabolic syndrome-related diseases through AI-enabled drug discovery. It collaborates with healthcare providers to gather and analyze de-identified patient data and bio-samples. The company's MOHSAIC® platform integrates multi-omics analysis, computational systems biology modeling, and targeted laboratory experiments to develop novel precision therapeutic concepts. These concepts are then commercialized through partnerships with established biopharma companies.
Wingtra is a Swiss drone manufacturer that designs the WingtraOne, a vertical take-off and landing VTOL fixed-wing drone that combines plane-like efficiency with VTOL versatility to deliver high-precision aerial data for surveying, mapping, and infrastructure projects. The platform supports sectors including construction, mining, agriculture, forestry, environmental monitoring, urban planning, and land management by capturing detailed data over large areas. Founded in 2014 and launching its market-ready product in 2017, Wingtra serves a global customer base through a network of surveying equipment dealers, enabling professionals to digitize and monitor surroundings with reliable flight performance.
Flyability
Series C in 2023
Flyability develops and manufactures flying drones for inspection and exploration of indoor, inaccessible, and confined spaces. Its flagship drone, Elios, is collision-tolerant and enables industrial inspectors to access complex indoor environments safely. The company provides flying kits, spare parts, training, and after-sales support. Founded in 2014 and headquartered in Lausanne, Switzerland, Flyability focuses on industrial inspection to reduce risk by enabling drone operation inside cities, buildings, and near people, supporting inspections of critical infrastructures such as power generation, oil and gas, and maritime facilities, as well as search and rescue and security applications.
Insolight
Venture Round in 2022
Insolight is an energy company founded in 2015 that specializes in the development and manufacturing of advanced solar panels. The company has achieved record efficiency levels of 29 percent for its solar modules, significantly lowering residential solar electricity costs. Insolight utilizes innovative optical technology that combines high efficiency with the ease of mounting similar to standard flat panels. The company has also demonstrated its capabilities through third-party validations, achieving 36 percent efficiency on lab prototypes and 29 percent on pre-industrial modules. Insolight's business model focuses on developing intellectual property, controlling wholesale distribution, and outsourcing manufacturing. Additionally, the company is engaged in creating photovoltaic systems aimed at reducing solar electricity costs in the agricultural sector, employing integrated tracking methods to optimize energy production based on the sun's position.
Beekeeper
Series C in 2022
Beekeeper is a mobile-first communication platform designed for non-desk employees. It facilitates real-time messaging and targeted streams, automating processes and reducing reliance on paper. The platform connects frontline workers with various operational systems and communication channels, providing resources such as schedules and paystubs to improve employee engagement and retention.
Bob W is a provider of short-stay accommodation services that offers an alternative to traditional hotels. The company operates a managed marketplace of serviced apartments that combine the quality standards and amenities of a lifestyle hotel with the authenticity and functionality of a home. Each apartment is locally designed, work-friendly, and equipped with hotel linens and professional cleaning services. Additionally, the accommodations feature fully equipped kitchens, access to local gyms, and curated breakfast options. This approach allows travelers to easily find and enjoy short-stay accommodations tailored to their needs while ensuring a high standard of service and ecological mindfulness.
Orbex Space
Series C in 2022
Founded in 2015, Orbex is a leading private launch services company in Europe, specializing in the small satellite industry. The company has developed a low carbon, high-performance micro-launch vehicle that supports the deployment of satellites into polar and sun-synchronous low Earth orbits from a modern launch site in central Europe. Orbex offers a flexible core launch service along with a range of supporting services aimed at simplifying the launch process for its customers. By operating from a European location, Orbex benefits from shorter supply lines, easier communication, and reduced operational costs. The company utilizes advanced materials and in-house technologies, including rocket engines and avionics, to ensure high reliability and flexible mission profiles, enabling timely launches for small, micro, and nano-satellites.
Founded in Munich, Germany in 2017, IRUBIS specializes in manufacturing Mid-Infrared (MIR) spectrometers and Attenuated Total Reflection (ATR) crystals. The company combines semiconductor technology with infrared spectroscopy to develop devices for analyzing protein-based drugs. IRUBIS offers a real-time bioprocess monitoring system using MIR spectroscopy, which measures glucose and lactate online without contamination risk. They also provide ATR crystals and accessory solutions.
Flyability
Series C in 2022
Flyability develops and manufactures flying drones for inspection and exploration of indoor, inaccessible, and confined spaces. Its flagship drone, Elios, is collision-tolerant and enables industrial inspectors to access complex indoor environments safely. The company provides flying kits, spare parts, training, and after-sales support. Founded in 2014 and headquartered in Lausanne, Switzerland, Flyability focuses on industrial inspection to reduce risk by enabling drone operation inside cities, buildings, and near people, supporting inspections of critical infrastructures such as power generation, oil and gas, and maritime facilities, as well as search and rescue and security applications.
tozero
Pre Seed Round in 2022
Tozero, founded in July 2022 in Munich, Germany, by Sarah Fleischer and Dr. Ksenija Milicevic Neumann, specializes in lithium-ion battery recycling technology. The company aims to accelerate decarbonization efforts by developing a scalable and sustainable machine for recovering critical materials such as lithium, nickel, cobalt, graphite, and manganese from various battery types. By enabling industries to reintroduce these valuable raw materials into the supply chain, Tozero contributes to more sustainable practices in battery production and reduces dependency on virgin resources.
German Version below:
marta offers a market place for families, people in need of care and European caregivers. We believe that, on the one hand everyone has the right to receive appropriate care and to age with dignity and on the other hand caregivers should be able to do their work under fair conditions.
We are working on software solutions to connect caregivers with families across Europe and we support both parties during the entire process. In our own families we have seen that the current market is characterized by non-transparent services and does not deliver adequate quality. It is out mission to change that.
That is why we at marta pursue the goal of making things better by applying our software solutions to fundamentally rebuilding the "24-hour" care market.
Deutsche Version:
marta bietet einen Marketplatz für Familien, pflegebedürftige Menschen und europäische Pflegekräfte. Aus unserer Sicht, hat zum einen jede/r das Recht darauf, angemessene Pflege zu erhalten und in Würde zu altern und zum anderen sollten Pflegekräfte unter fairen Bedingungen ihre Arbeit machen können.
Wir arbeiten an dem Bau von Softwarelösungen, um Pflegekräfte mit Familien in ganz Europa zu verbinden und während der Betreuung zu begleiten. In unseren eigenen Familien haben wir gesehen, dass der derzeitige Markt von intransparenten Dienstleistungen geprägt ist und keine angemessene Qualität liefert.
Deswegen verfolgen wir bei marta das Ziel, es durch unsere Softwarelösungen besser zu machen und den Markt der "24-Stunden" Pflege grundlegend neu aufzubauen.
Luminovo
Seed Round in 2022
Luminovo GmbH, founded in 2017 and based in Munich, Germany, specializes in providing artificial intelligence consulting and solutions tailored for the electronics industry. The company offers hybrid processing services designed to simplify and expedite the development and production processes of electronic products. Luminovo's innovative software facilitates data-driven insights for electronics designers, enhancing their ability to manage supply chains effectively. It empowers manufacturers by automating quoting and procurement processes, thereby fostering collaboration within the supply chain. This approach not only accelerates the path to market for electronic products but also promotes cost efficiency and sustainability in product development. Through its comprehensive offerings, Luminovo aims to reduce the time and resources required for bringing market-ready electronic products to fruition.
Piomic Medical
Series A in 2022
Piomic Medical is a developer of a non-invasive medical device aimed at treating chronic wounds, particularly leg and foot ulcers. The company has created the COMS® One Therapy System, a portable, hand-held device that utilizes optical and magnetic stimulation technologies to promote wound healing. This device is designed to be user-friendly, featuring a single button operation, and can be utilized in both clinical settings and patients' homes. Clinical studies have demonstrated that the COMS® system is safe and effective, resulting in accelerated wound closure, reduced pain, and improved quality of life for patients. By providing a lightweight and efficient solution, Piomic Medical addresses the significant challenge posed by hard-to-heal wounds, which affect millions of individuals and impose a considerable burden on healthcare systems worldwide.
Oper is a reliable technology partner that enables lenders to leverage their mortgage offerings. The company helps credit providers to launch digital credit products in a matter of days. Credit providers can simply configure their process and start selling, by using Oper's out-of-the-box modules.
The customers can integrate Fintech technologies into their process by choosing functionalities from Oper's Fintech partner app store.
Nuclera specializes in accelerating drug discovery by providing a protein prototyping system. Its eProtein Discovery™ platform enables scientists to rapidly produce and test proteins for research purposes.
ORCA Computing
Series A in 2022
ORCA Computing develops a photonic quantum computer designed to be scalable and flexible. Founded in 2019 and based in Oxford, United Kingdom, the company focuses on a photonic processor that uses quantum memories to store, synchronize, and buffer quantum operations, improving performance. Its modular, optical fiber–based architecture relies on telecoms photonics and off‑the‑shelf fiber and optical components to create a rack‑mounted platform. By exploiting photonic degrees of freedom, ORCA Computing aims to unlock new applications and accelerate innovation across industries.
Invasight
Seed Round in 2022
Invasight is a clinical biotech company based in Zurich, Switzerland, founded in 2019. The company specializes in advancing cell invasion research with the aim of accelerating the development of targeted therapies for invasive cancers. By focusing on the proteins involved in cancer cell invasion, Invasight aims to create therapies that minimize the side effects typically associated with conventional cancer treatments. This innovative approach seeks to provide cancer patients with effective and safe treatment options tailored to their specific needs.
Code Intelligence
Series A in 2022
Code Intelligence GmbH, founded in 2017 and based in Bonn, Germany, specializes in developing advanced security software for application developers. The company offers an automated application security testing platform that employs coverage-based fuzzing and symbolic code execution to help identify and rectify security vulnerabilities in code. By automating various software attack simulations, Code Intelligence enables organizations to implement continuous security testing, significantly reducing the level of expert knowledge required for setup. Their solutions are designed to enhance the reliability and security of software, serving a diverse clientele that includes major global corporations such as Bosch, Deutsche Börse Group, and Deutsche Telekom.
Therapixel
Series B in 2022
Therapixel SA is a company based in Valbonne, France, with additional locations across multiple countries, including Australia and China. Founded in 2013, Therapixel specializes in designing and developing medical image analytics software for surgeons, leveraging artificial intelligence to enhance surgical procedures. Their product portfolio includes Radvise, an automatic image reading solution; Fluid, a touchless medical image navigation system for surgery; Anywhere, a post-processing workstation; and CD-Feed, a solution for importing CDs from outpatient imaging exams. The company also focuses on AI-based software for breast cancer detection and characterization, providing healthcare professionals with pertinent information to support decision-making during surgeries while adhering to sterility constraints.
Helios.do
Seed Round in 2022
Leading sustainable banking alternative - 100% transparent and dedicated to limite climate change
Soter Analytics PTY LTD focuses on preventing musculoskeletal injuries in industrial workplaces through its innovative Soter Spine system, which combines wearable sensors and advanced analytics. The company provides devices that continuously monitor human movement, capturing health and locational data to identify at-risk movements and alert workers accordingly. By partnering with large industrial organizations, Soter integrates additional sensors, such as those for temperature and heart rate, to enhance safety and productivity. The company also offers an application that tracks long-term impacts and provides actionable recommendations for injury prevention. Founded in 2015 and based in Perth, Australia, Soter Analytics aims to set a new standard in workplace safety and ergonomics by leveraging AI-powered insights to foster a culture of safety and efficiency among workers.
Minut is a technology company established in 2014, with operations in Shenzhen, China, and Malmö, Sweden. It specializes in designing and manufacturing smart home security devices. Minut's flagship product, Point, is a camera-less device that monitors noise, temperature, motion, and other environmental factors within homes. When it detects anomalies, it sends alerts to users' smartphones, enabling them to maintain home security without compromising privacy.
holo|one is a software company developing “sphere” – the award-winning, standardized Mixed Reality (MR) platform solution. It hails from Switzerland, with offices in Zurich, the Bay Area, and Chongqing, China.
Veesion is a technology company specializing in gesture recognition for real-time detection of shoplifting within the retail sector. Founded in 2018 and based in Paris, France, Veesion utilizes deep learning algorithms to analyze footage from security cameras, identifying gestures indicative of theft. The system autonomously generates alerts that are sent to human operators for confirmation and subsequent action. This innovative software can be integrated with existing surveillance systems, allowing retailers and distributors to enhance their security measures while optimizing the allocation of security personnel. By providing an ethical and effective solution to combat shoplifting, Veesion is reshaping the standards of retail security.
Oxford Medical Products
Venture Round in 2022
Oxford Medical Products is focused on developing a breakthrough gastro-retentive hydrogel technology aimed at addressing weight loss challenges. The company has created a self-expanding capsule that occupies space in the stomach, effectively reducing hunger and promoting significant weight loss. This innovative solution is designed to expand rapidly upon ingestion, providing a prolonged feeling of satiety. The capsules gradually break down and pass naturally through the digestive system, offering an affordable and safe option for individuals seeking to manage their weight. Led by a diverse team of scientists, medical professionals, and entrepreneurs, Oxford Medical Products is dedicated to tackling one of the most pressing medical issues in today's society.
Founded in Zurich, Switzerland in 2018, Sleepiz develops a non-contact multidimensional sleep monitoring device. It tracks breathing, heart rate, and body movements with medical-grade accuracy, enabling diagnosis of sleep disorders and long-term patient-centric disease management.
Zero Point Motion
Seed Round in 2022
Zero Point Motion develops inertial sensing technology for precise positioning and navigation, combining cavity optomechanics with a hybrid micro-electro-mechanical system and photonic integrated circuit technology to deliver ultra-low-noise readouts of acceleration and rotation; its sensors include ultra-sensitive accelerometers and gyroscopes built on silicon photonics, enabling high-accuracy motion sensing for demanding applications, including defense, agritech, and autonomous vehicles.
Founded in 2018, 9T Labs specializes in manufacturing advanced 3D printers that produce carbon composites. Their proprietary technology combines software, additive manufacturing, and industry-standard materials to deliver digital composite production solutions. This enables manufacturers to create lighter structural parts with true 3D fiber orientation at a lower cost.
Memo Therapeutics
Series B in 2022
Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.
Scrona specializes in micro- and nanotechnology, focusing on simplifying these advanced fields for both consumers and industries. The company has developed a three-dimensional nano drip printing technology that facilitates rapid and cost-effective production. Scrona is centered on printhead development and collaborates with partners to provide comprehensive manufacturing equipment and next-generation products. This approach enables businesses to produce printed materials of high quality at reduced costs, thereby revolutionizing the landscape of micro- and nanofabrication.
Nanoleq develops and manufactures electric cables using stretchable electronics, serving sectors such as healthcare, robotics, aerospace, and electronics. Its products include shields and conductors for various applications.
Hylomorph
Series B in 2021
Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.
Medimaps Group
Venture Round in 2021
Medimaps Group develops medical software that enhances osteoporosis diagnosis by assessing bone microarchitecture. Its AI-driven imaging tools help clinicians select appropriate treatments and monitor outcomes, with future applications in dental and orthopedic fields.
Beekeeper
Convertible Note in 2021
Beekeeper is a mobile-first communication platform designed for non-desk employees. It facilitates real-time messaging and targeted streams, automating processes and reducing reliance on paper. The platform connects frontline workers with various operational systems and communication channels, providing resources such as schedules and paystubs to improve employee engagement and retention.
Kiutra
Venture Round in 2021
Kiutra GmbH, founded in 2018 and based in Munich, Germany, specializes in the development of refrigeration solutions, particularly for cryogen-free cooling applications. The company focuses on providing easy-to-use, turn-key cryostats that facilitate low-temperature investigations of material samples, thereby accelerating the development and testing of quantum hardware and related electronics. Kiutra's innovative cooling platforms achieve continuous sub-Kelvin temperatures without relying on liquid cooling media, such as helium-3, which is both rare and costly. This technology is essential for enabling cryogenic conditions in a compact and cost-efficient manner, making it applicable for advanced fields like quantum computing, quantum communications, and quantum sensing. By offering efficient cooling solutions, Kiutra supports research and industry customers in their pursuit of scalable quantum technologies.
PathoQuest
Series B in 2021
PathoQuest SAS, a spin-off from Institut Pasteur, is a biotechnology company specializing in advanced pathogen detection through metagenomics. The company employs next-generation sequencing (NGS) based testing to provide actionable reports for clinicians, biologists, and quality assurance managers in the biopharmaceutical industry. PathoQuest's proprietary sample preparation methods and extensive database of pathogen genomic information address current limitations in infectious agent detection. Their Viral Safety testing service, aimed at biopharmaceutical companies, has already generated revenue from several major firms, showcasing the company’s innovative approach to molecular diagnostics.
Comgy
Venture Round in 2021
Comgy GmbH, founded in 2017 and based in Berlin, Germany, specializes in digital metering solutions for the housing and energy sectors. The company offers a range of products including a sub-metering solution that enables users to efficiently read meters, alongside sensors and smoke alarms. Comgy provides a Meter Gateway Management application, which acts as a control center for remote device configuration and data processing, as well as a Meter Installation Manager application for the digital registration of radiator measurements, supported by photographic documentation. Additionally, its Polyglot gateway facilitates encrypted communication between meters, sensors, and its customer platform. Comgy's technology enhances the measurement, visualization, and billing processes of heat, water, and electricity consumption in real estate, promoting transparency and facilitating energy savings.
Groover
Venture Round in 2021
Groover is an innovative platform designed specifically for independent artists, focusing on music promotion and discovery. It has cultivated a community of 200,000 artists across more than 186 countries. The platform allows musicians to directly submit their music to media outlets, radio stations, playlists, and record labels, ensuring they receive valuable feedback from a vetted network of 3,000 music curators and professionals. With over two million feedback interactions on tracks, Groover provides artists with the opportunity to obtain honest insights and tangible sharing proposals, facilitating their growth and visibility in the competitive music industry.
Aktiia is a company focused on providing continuous and accurate blood pressure monitoring to address hypertension, a prevalent chronic condition affecting over 1.4 billion people globally. Founded on two decades of research, Aktiia has developed a unique tool that combines optical sensors with clinically validated software algorithms to measure blood pressure at the wrist. This innovative approach enables individuals to gain insights into their blood pressure patterns and understand the underlying causes of hypertension. By delivering personalized, continuous, and medical-grade blood pressure and heart rate data, Aktiia aims to enhance patient care and empower patients, researchers, and clinicians. The company's mission is to improve the accessibility, accuracy, and actionability of blood pressure management, ultimately contributing to better health outcomes and reducing the significant mortality associated with high blood pressure.
Seervision
Funding Round in 2021
Seervision AG is a Swiss startup founded in 2016 and based in Zurich, specializing in software for camera automation aimed at enhancing video production. Originally conceived at ETH Zurich to improve live lecture recording, the company has evolved into a robust enterprise with a focus on automating workflows in corporate studios, stage events, and educational environments. The Seervision Suite employs advanced video analysis algorithms that utilize motion control technology, integrating computer vision and machine learning to facilitate fully automated productions. This includes features such as autonomous camera tracking, facial recognition, and scene understanding, allowing for seamless integration into corporate settings and significantly simplifying live production processes. With a growing team of over 30 employees, Seervision is committed to making video production effortless and efficient.
Founded in 2017, Scewo designs and manufactures innovative electric wheelchairs for individuals with mobility impairments. Its flagship product is a stair-climbing wheelchair that combines wheels and tracks with an active control system, enabling users to navigate various terrains and obstacles.
Estateguru
Series A in 2021
Estateguru is a Pan-European marketplace facilitating property-backed loans for small and medium enterprises (SMEs), connecting them with global investors. It offers a seamless, cross-border digital service, bypassing traditional financial institutions.
Fractory is an online platform facilitating sheet metal fabrication. It connects users with partner service providers for various processes like laser cutting, plasma cutting, and metal bending. Incorporated in 2019, Fractory operates globally to streamline manufacturing.
Founded in Zurich, Switzerland in 2018, Sleepiz develops a non-contact multidimensional sleep monitoring device. It tracks breathing, heart rate, and body movements with medical-grade accuracy, enabling diagnosis of sleep disorders and long-term patient-centric disease management.
Humanoo is a digital health platform aimed at enhancing the physical and mental well-being of employees and insurance clients. The platform offers customized programs and innovative eHealth solutions in areas such as fitness, physiotherapy, yoga, mindfulness, and nutrition, helping users achieve their health goals. By providing comprehensive decentralized analysis, Humanoo enables companies and insurers to gain insights into the health of their employees or clients, facilitating measurable improvements. The team, comprised of 65 professionals from 15 countries, includes software developers, designers, marketing and sales specialists, as well as health and wellness experts such as sports scientists, nutritionists, yoga instructors, and physiotherapists. Humanoo's mission is to motivate individuals to maintain a healthy lifestyle and improve their overall productivity.
Salonkee is a software company that offers a SaaS platform for online salon and beauty appointment bookings. The platform supports online reservations, quick search for services or salons, and customer management with POS capabilities. It provides notifications via email and SMS, automated appointment reminders and summaries, and tools for editing or rescheduling. The software also covers back-office needs such as inventory and stock management, warehouse management, analytics on business development, and marketing support. The solution targets hair and cosmetics industries and enables salon operators to manage appointments, inventory, and customer communications from a single system. The company was founded in 2016 and is based in Luxembourg.
Otoqi develops an automotive management platform that streamlines vehicle logistics throughout their lifecycle. Its solutions include delivery services, concierge transfers between sites, fleet management, and more, enabling dealerships to enhance operational efficiency, improve customer satisfaction, and drive sales growth.
Byrd is a logistics company that operates a fulfillment network designed to connect online merchants with an international warehouse system. This enables retailers to provide advanced shipping options globally without the need to establish their own logistics infrastructure. The company’s platform seamlessly integrates with major e-commerce systems, allowing retailers to enhance their service offerings and improve customer proximity. Byrd's technology-driven solution facilitates real-time stock tracking and first-mile shipping services, including item pick-up and packaging, accessible via a mobile application. This comprehensive approach aims to support both private and business customers in efficiently managing their shipping needs.
Threatray
Seed Round in 2021
Threatray is a cybersecurity company that specializes in code-based threat intelligence through its innovative malware threat search and analytics software. By creating searchable and correlatable repositories of extensive malware data, Threatray equips enterprise security and incident response teams with the necessary tools to gain a comprehensive understanding of cyber threats. The company's advanced analytics capabilities allow for in-depth analysis of data streams at the code level, facilitating the detection of similarities with known threats and the rapid identification of previously unknown malicious artifacts. This enables organizations to enhance their defenses against data leaks and better protect sensitive information.
ecoRobotix
Venture Round in 2021
ecoRobotix is a Swiss developer of autonomous weeding machines for row crops, meadows, and intercropping cultures. The company builds systems that use vision, cameras, GPS RTK, and sensors to follow crop rows, identify weeds, and guide robotic arms to apply micro-doses of herbicide directly to target weeds, enabling precision spraying and reducing chemical use. Its solutions aim to lower environmental impact and farming costs by enabling ecological and economical weed control. Founded in 2011 and based in Yverdon-les-Bains, Switzerland, ecoRobotix markets platforms that cover inter-row spaces as well as crop rows, delivering substantial reductions in chemical applications while maintaining yields.
Sympatient
Seed Round in 2021
Sympatient develops virtual reality-based psychotherapy treatments for anxiety disorders. It offers apps like Otemi for stress management and Invirto for independent anxiety therapy at home. The company combines digital therapeutics with therapist sessions, providing accessible personalized mental health care.
Stake is a digital platform that facilitates real estate investment, allowing individuals to invest in income-generating rental properties quickly and easily. The platform aims to modernize real estate investment by making it accessible to a broader audience. Stake achieves this by breaking down properties into smaller, investable shares, thereby enabling users to purchase stakes in residential properties. This approach not only democratizes real estate investment but also enhances transparency and profitability for investors. Through its innovative model, Stake provides a streamlined way for individuals to engage in the real estate market without the complexities traditionally associated with property investment.
Fineheart
Series B in 2021
Fineheart is a France-based medical device company specializing in innovative technologies for cardiovascular care. It focuses on the development of implantable cardiac devices aimed at treating cardiovascular diseases. The company's flagship product is a novel, wirelessly powered, fully implantable mechanical circulatory support device. This device is designed to optimize cardiac output while preserving the heart's natural contractility, thereby enabling patients to restore normal cardiac function. Fineheart's technology aims to improve the quality of life for heart failure patients, allowing them to return to normal daily activities.
EarlySight
Seed Round in 2021
EarlySight, a Lausanne-based medical device company, develops technology to detect and treat eye diseases at an early stage. Its flagship work includes a fundus camera that images the retina with high detail by combining eye illumination with real time ocular aberration correction. The company also leverages cellular level imaging and transscleral illumination to monitor day to day treatment effects in a non invasive manner, enabling eye specialists to visualize the morphology of retinal cells. Founded in 2016, EarlySight aims to bring its imaging technology to clinics to improve early diagnosis and treatment of ocular conditions.
Qnami AG is a Swiss company that specializes in the development of quantum sensing technologies for non-invasive magnetic imaging at the nanoscale. Founded in 2017 and based in Basel, Qnami's flagship products include the ProteusQ, a magnetic imaging microscope, and the Quantum Diamond, which features diamond probes with a single nitrogen-vacancy center for high-resolution imaging. These technologies allow for advanced applications in various fields, including multiferroic antiferromagnets, magnetic random-access memory (MRAM), and superconductivity. By enabling researchers and industries to measure electric and magnetic fields with exceptional sensitivity, Qnami enhances the capabilities of imaging techniques and supports groundbreaking scientific studies and industrial advancements.
rready offers a SaaS platform for innovation management, empowering employees to drive intrapreneurship. It facilitates idea sourcing, validation, and implementation, fostering cultural change and generating business impact.
Onward
Convertible Note in 2021
Onward is a company focused on developing mobile applications and online platforms that assist users in modifying compulsive behaviors related to technology and financial management. It combines data science and artificial intelligence to create personalized programs aimed at addressing issues such as excessive screen time, social media use, gambling, and spending habits. The company also offers financial wellness solutions, including direct savings plans and emergency lending options to help individuals build financial security. Established in 2015 and based in Los Angeles, California, Onward's mission centers around restoring a balance between technology and life by providing accessible and non-judgmental resources for behavior change. Through collaboration with clinical advisors from UCLA, Onward seeks to utilize advanced behavioral science to reach a broad audience globally.